Diagnostics Pipeline: FDA Opens Path for Blood Tests Assessing Genetic Cancer Risk
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
First marketing authorization of a blood test assessing genetic variants related to cancer opens the door for clearance of similar tests.
From - Laboratory Industry Report
Qiagen was the most active firm of the period with a trio of new product launches, including the US launch of…
From - Laboratory Industry Report
March was the most intense month of the year so far for new diagnostic products highlighted by 23andMe's launch of a new…
From - Laboratory Industry Report
After a slow January, new product development picked up steam in February. Here's a rundown of the key new launches…
From - Laboratory Industry Report
Late December through January was fairly slow for new product launches in terms of both volume and impactful-ness. Here's a rundown of…
From - Laboratory Industry Report
Here are some of the more notable launches from the busy October-November period…
From - Laboratory Industry Report
After a slow August, product launches were up in volume but not dramatic impact. Here's a rundown of the new diagnostics to hit the market in…
From - Laboratory Industry Report
After a busy July, the pace and volume of new product launches slowed significantly in August…
From - Laboratory Industry Report
Thermo Fisher Scientific and Invitae were among the firms releasing multiple new products from the end of June through the third week of July. Here's a more…